The Allstate Corp (NYSE: ALL) CEO discloses planned insider share sales
Rhea-AI Filing Summary
The Allstate Corporation’s Chairman, President and CEO Thomas J. Wilson reported multiple open-market sales of Allstate common stock on January 2, 2026. The Form 4 shows four sale transactions of common stock at weighted average prices of $204.0964, $204.8644, $206.1694, and $206.9005, with corresponding post-transaction direct beneficial ownership levels of 120,826.303, 113,590.303, 112,450.303, and 111,215.303 shares.
The filing states these sales were executed under a Rule 10b5-1 trading plan adopted on June 27, 2025. It also notes that Wilson’s holdings include additional indirect ownership through several GRATs, a 401(k) plan, and a GRAT remainder trust, reflecting substantial ongoing equity exposure to Allstate.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 7,196 | $204.0964 | $1.47M |
| Sale | Common Stock | 7,236 | $204.8644 | $1.48M |
| Sale | Common Stock | 1,140 | $206.1694 | $235K |
| Sale | Common Stock | 1,235 | $206.9005 | $256K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $203.505 to $204.50. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request. The sale transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted on June 27, 2025. Balance also reflects 16.812 shares acquired during the period of October 3, 2025 through January 2, 2026, through the Shareowner Service Plus Plan, which reinvests dividends paid on The Allstate Corporation common shares. Reflects weighted average sale price for open-market sales transactions reported herein. Actual sales prices ranged from $204.51 to $205.32. The reporting person provided to the issuer, and will provide to any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $205.70 to $206.59. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $206.85 to $207.05. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.
FAQ
What insider transaction did ALL (Allstate) report in this Form 4?
The Form 4 reports that Thomas J. Wilson, Chairman, President and CEO of The Allstate Corporation, executed multiple open-market sales of Allstate common stock on January 2, 2026.
Were the Allstate (ALL) insider sales made under a Rule 10b5-1 trading plan?
Yes. The filing states that the sale transactions were effected pursuant to a Rule 10b5-1 trading plan that was adopted on June 27, 2025.
What price ranges are disclosed for the Allstate (ALL) stock sales?
The weighted average prices reflect ranges for the open-market sales. The filing notes actual sale price ranges of $203.505 to $204.50, $204.51 to $205.32, $205.70 to $206.59, and $206.85 to $207.05 for the respective transactions.